Tag: CytoAgents

CytoAgents, Quotient Sciences to take COVID-19 drug candidate GP1681 into human trials

pharmanewsdaily- April 29, 2020

US biotech company CytoAgents has joined forces with CDMO and CRO services provider Quotient Sciences to accelerate the development of its COVID-19 drug candidate GP1681 into ... Read More